Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
艾比玛特医药科技(上海)有限公司 logo — Empowering scientists with the future of antibody innovation...

艾比玛特医药科技(上海)有限公司

Empowering scientists with the future of antibody innovation and discovery.

Founded 2007 4 employees Series B Total: $33.00M Biotechnology, Pharmaceutical

General Information

Company Name 艾比玛特医药科技(上海)有限公司
Founded Year 2007
Employees 4
Industries Biotechnology, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with 艾比玛特医药科技(上海)有限公司. To contact 艾比玛特医药科技(上海)有限公司, visit ab-mart.com.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About 艾比玛特医药科技(上海)有限公司

Abmart is a Shanghai-based biotechnology and pharmaceutical company founded in 2007. It specializes in antibody customization and related services, aiming to empower scientists with the future of antibody innovation and discovery. The company excels in leveraging advanced technology and products to develop antibodies, study protein complexes, discover new targets, identify markers, and manufacture antibody drugs on a large scale. Their Series B investment of CNY20.00M on 12 June 2018 saw participation from prominent investors including Share Capital, 朗盛投资, Puming Dianli Xitong Gongcheng, Unity Asset Management, and Parkland Group. Abmart's goal is to reshape the industry and provide scientists with complementary antibodies, making it a promising player in the biotech and pharmaceutical sectors.

Taxonomy: antibodies, antibody innovation, protein research, target discovery, pharmaceutical manufacturing

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B CNY20.00M 5
Share Capital 朗盛投资
Share Capital, 朗盛投资 +3
12 Jun 2018
Series A CNY10.00M 1
InnoSpring
06 Mar 2017
Angel Round CNY3.00M 1
Northern Light Venture Capital
Northern Light Venture Capital
01 Jan 2008

艾比玛特医药科技(上海)有限公司 Alternatives & Competitors

View All Alternatives
艾比玛特医药科技(上海)有限公司 vs
DEM Biopharma, Inc.
DEM Biopharma, Inc. United States

Novel Target for Solid Tumors

20 employees
Biotechnology, Life Sciences
艾比玛特医药科技(上海)有限公司 vs
BAO PHARMA
BAO PHARMA China

Acting on the Needs of Patients

Series C
6 employees
Biopharma, Biotechnology
艾比玛特医药科技(上海)有限公司 vs
CRYSTAL BIOSCIENCE INC.
CRYSTAL BIOSCIENCE INC. United States

Harnessing Avian Innovation to Create Breakthrough Therapeutic Antibodies

11-50 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About 艾比玛特医药科技(上海)有限公司

Empowering scientists with the future of antibody innovation and discovery.
艾比玛特医药科技(上海)有限公司 was founded in 2007.
艾比玛特医药科技(上海)有限公司 operates in Biotechnology and Pharmaceutical. Its work centres on antibodies, antibody innovation, protein research and target discovery.
艾比玛特医药科技(上海)有限公司 has approximately 4 employees.
艾比玛特医药科技(上海)有限公司 has completed 3 funding rounds, raising a total of $33.00M. The latest funding stage is Series B.
Top alternatives and competitors to 艾比玛特医药科技(上海)有限公司 include DEM Biopharma, Inc., BAO PHARMA, CRYSTAL BIOSCIENCE INC., Macromoltek Inc., Cube Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
艾比玛特医药科技(上海)有限公司 and DEM Biopharma, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 艾比玛特医药科技(上海)有限公司, https://bouncewatch.com/company/abmart, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes